Plasmin degradation of cross-linked fibrin
- PMID: 6223558
- DOI: 10.1111/j.1749-6632.1983.tb23260.x
Plasmin degradation of cross-linked fibrin
Abstract
On the basis of structural studies of both degrading insoluble cross-linked fibrin and of soluble derivatives, we have developed a model to explain the principal structural and physical features of plasmic degradation of cross-linked fibrin in vitro from the completely intact matrix to terminally degraded soluble derivatives. The critical event of solubilization occurs only as the result of coincident cleavages at complementary sites in the basic two-stranded half-staggered overlap fibrin structure, resulting in the release of two-stranded complexes held together by noncovalent forces. The four smallest complexes that are released into solution have structures corresponding to DD/E, DY/YD, YY/DXD, and YXD/DXY. The protein initially solubilized has a constant composition with a predominance of large derivatives that are composed of at least one fragment from each of the two strands of the protofibril. Following their release into solution the larger complexes are converted in vitro to smaller ones by the continued action of plasmin, so that the complex found following prolonged digestion is DD/E. It is proposed that this newly defined group of complexes represents the major form of circulating plasmic derivatives of cross-linked fibrin.
Similar articles
-
A molecular model of plasmic degradation of crosslinked fibrin.Semin Thromb Hemost. 1982 Jan;8(1):25-35. doi: 10.1055/s-2007-1005040. Semin Thromb Hemost. 1982. PMID: 6460319
-
Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.J Clin Invest. 1980 Nov;66(5):1033-43. doi: 10.1172/JCI109931. J Clin Invest. 1980. PMID: 6448866 Free PMC article.
-
Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes.Blood. 1980 Sep;56(3):456-64. Blood. 1980. PMID: 6447526
-
Fibrin(-ogen) interactions with plasmin.Haemostasis. 1977;6(1):2-25. doi: 10.1159/000214161. Haemostasis. 1977. PMID: 140113 Review.
-
Fibrin degradation products. A review of structures found in vitro and in vivo.Ann N Y Acad Sci. 2001;936:594-610. Ann N Y Acad Sci. 2001. PMID: 11460518 Review.
Cited by
-
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.J Exp Med. 1985 Dec 1;162(6):1983-97. doi: 10.1084/jem.162.6.1983. J Exp Med. 1985. PMID: 3906018 Free PMC article.
-
PEGylation of Truncated Streptokinase Leads to Formulation of a Useful Drug with Ameliorated Attributes.PLoS One. 2016 May 18;11(5):e0155831. doi: 10.1371/journal.pone.0155831. eCollection 2016. PLoS One. 2016. PMID: 27192220 Free PMC article.
-
Sculpting the blank slate: how fibrin's support of vascularization can inspire biomaterial design.Acta Biomater. 2014 Apr;10(4):1515-23. doi: 10.1016/j.actbio.2013.07.043. Epub 2013 Aug 7. Acta Biomater. 2014. PMID: 23933102 Free PMC article. Review.
-
The role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke.PLoS One. 2015 Feb 13;10(2):e0118301. doi: 10.1371/journal.pone.0118301. eCollection 2015. PLoS One. 2015. PMID: 25680111 Free PMC article.
-
Role of fibrin D-dimer testing in emergency medicine.Emerg Med J. 2003 Jul;20(4):319-25. doi: 10.1136/emj.20.4.319. Emerg Med J. 2003. PMID: 12835339 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources